Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) (CHALLAH)
This study is ongoing, but not recruiting participants.
Sponsor:
Baylor College of Medicine
Collaborators:
Texas Children's Hospital
The Methodist Hospital System
Brigham and Women's Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
National Marrow Donor Program
The EMMES Corporation
Duke University
Beth Israel Deaconess Medical Center
Children's Hospital Los Angeles
Children's Hospital Boston
University of Miami
Hackensack University Medical Center
University of California, Los Angeles
Information provided by (Responsible Party):
Helen Heslop, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00711035
First received: June 20, 2008
Last updated: March 20, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2013 |
| Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |